Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT05387057Not ApplicableCompleted

Effectiveness of a Novel Exergame-Based Training Concept for Older Adults With Mild Neurocognitive Disorder

Role: lead

NCT04996654Not ApplicableCompleted

Feasibility of a Novel Exergame-Based Training Concept for Older Adults With Mild Neurocognitive Disorder

Role: lead

NCT04872153Not ApplicableCompleted

Exergames in In-patient Rehabilitation

Role: lead

NCT04963335Not ApplicableUnknown

Effects of a User-centered Exergame Training on Motor and Cognitive Functions in PwMS

Role: lead

NCT04587895Not ApplicableUnknown

Feasibility Study of an Individualized Exergame Training for Older Adults With MI and/or UI (VITAAL)

Role: lead

NCT03676452Not ApplicableCompleted

The Effects of an Exergame Training on Body and Brain of Older Adults

Role: lead

All 6 trials loaded